State medical cannabis programs failing to make enough progress, advocacy group finds
By Adam Goldstein for Maryland Matters WASHINGTON — A report from a patient advocacy group found the future of medical cannabis in the states is hazy unless costs are decreased, product safety standards are improved, and civil rights are strengthened...
Read more